Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-12 Maintenance in Refractory HIV-Associated Non-Hodgkin's Lymphoma
NCT00003575Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1999
- Primary completion
- Apr 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Started Jan 1999; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003575.